Weill Cornell Medicine’s Post

The Substance Use Education Team is offering a free webinar by, Dr. Glenn Sterner, Assistant Professor, Criminal Justice / Site Coordinator, The Greater Philadelphia Office, Criminal Justice Research Center, on Tuesday, July 16, 2024, at 12:00 PM. Dr. Sterner is a returning presenter who will be giving an update on the latest substance use trends in our Commonwealth. Description: Is it still the opioid epidemic, or are we facing something different? During Substance Use and Trends in Pennsylvania, we will discuss the changing nature of what we have come to refer to as the "opioid epidemic" in Pennsylvania and beyond. We will be highlighting some significant changes that are important as we consider prevention, treatment, and recovery support services to address this critical public health and safety issue. What will you learn? Definitions of substance use and substance use disorders, and the difference between them Current trends of substance use and related statistics in Pennsylvania Information on new drugs and substances in our communities including Xylazine, stimulants, and Fenethylline Strategies for identifying evidence-based practices that address substance use and substance use disorders #pennstateextension

We are evolving with our care of patients with Alcohol Use Disorder and trying to reduce stigma so more get into care. Consider removing the word alcoholic from your vocabulary and replacing it with Alcohol Use Disorder (AUD). Its not alcohol abuse its alcohol misuse. Instead of alcoholic hepatitis its alcohol-associated hepatitis. See a recent lecture here on management of AUD from the hepatologist's perspective geared for the PCP. 😎 https://lnkd.in/gKC-FAvA #AASLD, #EASL, #primarycare, Scripps Health, Scripps Research, American Association for the Study of Liver Diseases (AASLD), #AUD, #Alcohol

Imagine a simple blood test that could detect Postpartum Pepression (PPD) ❗before❗ symptoms take hold. Researchers at Johns Hopkins are making this a reality by identifying biological markers for PPD. This breakthrough could lead to earlier interventions, faster treatments, and better outcomes for mothers/birthing people and their babies. PPD affects 1 in 5 mothers/birthing people. This innovative approach could be a game-changer, offering hope and support early. Read the full article via link in bio 🔗 @mother.ly #PostpartumDepression #MentalHealthAwareness #MaternalMentalHealth #EarlyIntervention #SupportMothers

The University of Georgia College of Pharmacy has received nearly $1.2 million from the Georgia Opioid Crisis Abatement Trust to address the opioid epidemic in rural communities. The two-year initiative will train and support pharmacists in these areas to provide critical resources, reduce stigma, and establish support networks.

Today is World Hemophilia Day, a day created by the World Federation of Hemophilia to educate people about the causes, symptoms, diagnosis, and management of haemophilia, as well as the challenges faced by those living with the condition. This year's theme centres around "Equitable access for all: recognizing all bleeding disorders." and advocates for "Treatment for All," where individuals with inherited bleeding disorders receive care without discrimination based on the type of bleeding disorder, gender, age, or geographical location. As a global medical communications agency with a strong heritage working with clients to advance the treatment of haemophilia, Porterhouse Medical is proud to support the bleeding disorders community in striving for a world where everyone, whether affected by haemophilia A or B, von Willebrand disease (VWD), or any other bleeding disorder, has equal access to diagnosis, treatment, and comprehensive care. Today and every day, let's work towards a future where treatment is available to all and where all individuals can live their lives to the fullest. 🩸 https://ow.ly/jyhv50RhSuz #WorldHemophiliaDay #Haemophilia #BleedingDisorders #TreatmentForAll #HealthcareEquity

Recent research suggests that mifepristone itself may also cause complications of infection and mental health issues through direct pharmacologic effects. Mifepristone also blocks glucocorticoid receptors which may contribute to an impaired inflammatory response, increasing the risk of infection. [56] "In addition, it causes the release of inflammatory cytokines which have been implicated in causing depression..." Read more: AAPLOG Practice Guideline 8: Medication Abortion: https://buff.ly/3SVAZGu #aaplog #integrityinmedicine #allianceforhippocraticmedicine #aaplogmedicalevidence #aaplogscientificscholarship #aaplogfdalawsuit #aaplogmedicationabortion #joinaaplogtoday

Diagnosis and Management of Pelvic Venous Disorders in Women https://lnkd.in/dqg3yw9g Read the special section on deep venous interventions here: https://lnkd.in/daep2eff

More and more discussions are emerging about the connection between cardiovascular diseases and male and female sexual difficulties, affecting arousal, desire, and orgasm. According to the American Heart Association, men commonly report reduced sexual desire and issues with achieving and maintaining an erection due to cardiovascular disease. Additionally, the disease and its treatment can impact a man's ability to achieve orgasm. On the other hand, women are more likely to face challenges such as decreased sexual desire, orgasm problems, vaginal dryness, and pain during intercourse. #CardiovascularHealth #SexualWellness #HeartDiseaseAwareness #sexualhealth #sexualdysfunction

The opioid epidemic has entered a devastating fourth wave, now increasingly affecting stimulant users. This convergence of substance use underscores the urgent need for integrated public health strategies that address the complexities of polysubstance abuse. The article "Stimulant Users Are Caught in Fatal Fourth Wave of Opioid Epidemic" highlights the critical importance of comprehensive approaches to substance use disorders. 𝗔𝘁 𝗛𝗘𝗔𝗟 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹, we’re deeply committed to being part of the solution with programs like 𝗛𝗘𝗔𝗟-𝗢. Our tablet-based solution delivers essential patient information, enabling doctors to screen, educate, and assess patients efficiently—helping to identify risks like opioid misuse or polysubstance use early. By bridging the information gap between patients and providers, we aim to empower better decision-making, improve outcomes, and support public health efforts in tackling this crisis. Let’s continue working together to implement multifaceted interventions that consider the intertwined nature of substance use. By combining technology and proactive care, we can better support affected individuals and mitigate this escalating crisis. #PublicHealth #OpioidCrisis #SubstanceAbuse #HarmReduction #IntegratedCare #HealClinical #HEALO

Article Published 🌟 I’m delighted to share that our latest article, "Symptoms of Panic Disorder May Lead to a Potential Misdiagnosis as a Cardiopulmonary Disease, Particularly in Rural Areas," has been published in the Journal of Pakistan Medical Association (JPMA). This article highlights the challenges in distinguishing panic disorder from cardiopulmonary conditions, especially in resource-limited rural settings. Key points include: 🔹 The overlap of symptoms like palpitations and chest tightness leading to diagnostic challenges. 🔹 How misdiagnosis can result in unnecessary treatments and strain on healthcare systems. 🔹 The need for better physician training and mental health resources in rural areas Read more here: https://lnkd.in/d9e9qy6v